| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9847 |
| Human Intestinal Absorption | HIA+ | 1.0000 |
| Caco-2 Permeability | Caco2+ | 0.7275 |
| P-glycoprotein Substrate | Non-substrate | 0.7394 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9502 |
| Non-inhibitor | 0.9668 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.7787 |
| Distribution |
| Subcellular localization | Lysosome | 0.7045 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7301 |
| CYP450 2D6 Substrate | Non-substrate | 0.8043 |
| CYP450 3A4 Substrate | Non-substrate | 0.6388 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.8530 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.5981 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8314 |
| CYP450 2C19 Inhibitor | Inhibitor | 0.8936 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.7907 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7048 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9487 |
| Non-inhibitor | 0.8417 |
| AMES Toxicity | AMES toxic | 0.9717 |
| Carcinogens | Non-carcinogens | 0.8714 |
| Fish Toxicity | High FHMT | 0.6847 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9390 |
| Honey Bee Toxicity | High HBT | 0.5367 |
| Biodegradation | Not ready biodegradable | 0.9618 |
| Acute Oral Toxicity | III | 0.8004 |
| Carcinogenicity (Three-class) | Non-required | 0.7503 |